| Date Filed | Type | Description |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Agresta Samuel (Chief Medical Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 60,000 options to buy
@ $8.38, valued at
$502.8k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Agresta Samuel (Chief Medical Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 125,000 options to buy
@ $14.87, valued at
$1.9M
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/22/2020 |
3
| Agresta Samuel (Chief Medical Officer) has filed a Form 3 on Foghorn Therapeutics Inc. |
| 06/18/2020 |
4
| Agresta Samuel (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $0.92, valued at
$27.6k
|
|
| 10/16/2019 |
4
| Agresta Samuel (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 60,000 options to buy
@ $1.14, valued at
$68.4k
|
|
| 10/16/2019 |
3
| Agresta Samuel (Director) has filed a Form 3 on INFINITY PHARMACEUTICALS, INC. |
| 01/07/2019 |
4
| Agresta Samuel (Chief Medical Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 62,596 options to buy
@ $1.24, valued at
$77.6k
|
|
| 08/07/2018 |
4
| Agresta Samuel (Chief Medical Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 300,000 options to buy
@ $1.8, valued at
$540k
|
|
| 08/07/2018 |
3
| Agresta Samuel (Chief Medical Officer) has filed a Form 3 on INFINITY PHARMACEUTICALS, INC. |